Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Publikationen des W. G. Kerckhoff-Instituts     Display Documents



ID: 474541.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Publikationen des W. G. Kerckhoff-Instituts
Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury
Authors:Egemnazarov, B.; Sydykov, A.; Schermuly, R. T.; Weissmann, N.; Stasch, J. P.; Sarybaev, A. S.; Seeger, W.; Grimminger, F.; Ghofrani, H. A.
Date of Publication (YYYY-MM-DD):2009
Title of Journal:Am J Physiol Lung Cell Mol Physiol
Volume:296
Issue / Number:3
Start Page:L462
End Page:9
Audience:Not Specified
Abstract / Description:The protective effects of nitric oxide (NO), a physiological activator of soluble guanylyl cyclase (sGC), have been reported in ischemia-reperfusion (I/R) syndrome of the lung. Therefore, we studied the effects of BAY 41-2272, a novel sGC stimulator, on I/R injury of the lung in an isolated intact organ model. Lung injury was assessed by measuring weight gain and microvascular permeability (capillary filtration coefficient, K(fc)). Release of reactive oxygen species (ROS) into the perfusate was measured during early reperfusion by electron spin resonance (ESR) spectroscopy. Rabbit lungs were treated with BAY 41-2272, N(G)-monomethyl-L-arginine (L-NMMA), or NO to evaluate the effects on I/R-induced lung injury. In untreated lungs, a dramatic rise in K(fc) values and weight gain during reperfusion were observed, and these results were associated with increased ROS production. Both, BAY 41-2272 and L-NMMA significantly attenuated vascular leakage and suppressed ROS release. Additional experiments showed that BAY 41-2272 diminished PMA-induced ROS production by NADPH oxidase. A pharmacological inhibition of the enzyme with consequent reduction in ROS levels decreased I/R injury. NO had only marginal effect on I/R injury. Thus BAY 41-2272 protects against I/R-induced lung injury by interfering with the activation of NADPH oxidases.
Free Keywords:Animals; Blood Pressure/drug effects; Capillary Permeability/drug effects; Enzyme Activation/drug effects; Guanylate Cyclase/*metabolism; Lung/blood supply/drug effects/physiopathology; Lung Injury/*enzymology/physiopathology/*prevention & control; Male; NADPH Oxidase/metabolism; Nitric Oxide/metabolism/pharmacology; Pulmonary Artery/drug effects/physiopathology; Pyrazoles/*pharmacology; Pyridines/*pharmacology; Rabbits; Reactive Oxygen Species/metabolism; Reperfusion Injury/*enzymology/*prevention & control; Solubility; Tetradecanoylphorbol Acetate/pharmacology; omega-N-Methylarginine/pharmacology
External Publication Status:published
Document Type:Article
Communicated by:N. N.
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:Departments of Internal Medicine II, University Hospital Giessen and Marburg, Giessen, Germany.
Identifiers:ISSN:1040-0605 (Print) 1040-0605 (Linking)
URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=..
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.